Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan

Prediction model for hypertension risk in Chinese is still lacking. We aimed to propose prediction models for new-onset hypertension for ethnic Chinese based on a prospective cohort design on community, which recruited 2506 individuals (50.8% women) who were not hypertensive at the baseline (1990–91). Total 1029 cases of new-onset hypertension developed during a median of 6.15 (interquartile range, 4.04–9.02) years of follow-up. In the clinical model, gender (2 points), age (8 points), body mass index (10 points), systolic blood pressure (19 points) and diastolic blood pressure (7 points) were assigned. The biochemical measures, including white blood count (3 points), fasting glucose (1 point), uric acid (3 points), additional to above clinical variables, were constructed. The areas under the receiver operative characteristic curves (AUCs) were 0.732 (95% confidence interval (CI), 0.712–0.752) for the point-based clinical model and 0.735 (95% CI, 0.715–0.755) for the point-based biochemical model. The coefficient-based models had a good performance (AUC, 0.737–0.741). The point-based clinical model had a similar net reclassification improvement as the coefficient-based clinical model (P=0.30), and had a higher improvement than the point-based biochemical model (P=0.015). We concluded that the point-based clinical model could be considered as the first step to identify high-risk populations for hypertension among Chinese.

[1]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[2]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[3]  W. Elliott Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome , 2008 .

[4]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[5]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[6]  K. Chien,et al.  Two-year change in body mass index and subsequent risk of hypertension among men and women in a Taiwan community , 2009, Journal of hypertension.

[7]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[8]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[9]  N. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[10]  P. Ridker,et al.  A prospective study of plasma lipid levels and hypertension in women. , 2005, Archives of internal medicine.

[11]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[12]  Nader Rifai,et al.  Multiple Biomarkers and the Risk of Incident Hypertension , 2007, Hypertension.

[13]  S. Pocock,et al.  Incidence , , 2018 .

[14]  Nancy R Cook,et al.  Prediction of incident hypertension risk in women with currently normal blood pressure. , 2009, The American journal of medicine.

[15]  J. Oppert,et al.  Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting , 2002, International Journal of Obesity.

[16]  K. Chien,et al.  Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan , 2008, Journal of hypertension.

[17]  F. Hu,et al.  A prediction model for type 2 diabetes risk among Chinese people , 2009, Diabetologia.

[18]  M. Jokela,et al.  Validating the Framingham Hypertension Risk Score: Results From the Whitehall II Study , 2009, Hypertension.

[19]  A. LaCroix,et al.  The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations. , 1990, American journal of preventive medicine.

[20]  K. Chien,et al.  Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. , 2005, Atherosclerosis.

[21]  L. Irwig,et al.  Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. , 2008, Archives of internal medicine.

[22]  K. Chien,et al.  Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a community-based cohort study in Taiwan , 2007, Journal of hypertension.

[23]  P. Vokonas,et al.  Uric Acid and the Development of Hypertension: The Normative Aging Study , 2006, Hypertension.

[24]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[25]  F. Hu,et al.  patient-oriented and epidemiological research Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese , 2007 .

[26]  Stanley Lemeshow,et al.  The Multiple Logistic Regression Model , 2013 .

[27]  P. Ridker,et al.  C-reactive protein and the risk of developing hypertension. , 2003, JAMA.

[28]  T. Erlinger,et al.  Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins Precursors Study. , 2008, Archives of internal medicine.

[29]  D. Levy,et al.  A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study , 2008, Annals of Internal Medicine.

[30]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[31]  M. Janghorbani,et al.  Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. , 2005, Diabetes research and clinical practice.

[32]  F. Hu,et al.  Plasma uric acid and the risk of type 2 diabetes in a Chinese community. , 2008, Clinical chemistry.

[33]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[34]  C-reactive protein and the risk of developing hypertension. , 2003 .

[35]  Y. T. Lee,et al.  Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. , 1999, Atherosclerosis.

[36]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[37]  G. Berti,et al.  Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. , 1980, Clinical chemistry.

[38]  G. Cutter,et al.  Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. , 1982, Preventive medicine.

[39]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[40]  S. T. Buckland,et al.  An Introduction to the Bootstrap. , 1994 .

[41]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[42]  D. Levy,et al.  Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence , 2005, Hypertension.

[43]  J. Manson,et al.  Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes , 2004, Diabetologia.

[44]  R. D'Agostino,et al.  Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.

[45]  F. Sung,et al.  Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. , 2000, Journal of clinical epidemiology.

[46]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.

[47]  M. Stampfer,et al.  Diet and lifestyle risk factors associated with incident hypertension in women. , 2009, JAMA.

[48]  K. Chien An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes , 2007, Diabetes Care.

[49]  T. Erlinger,et al.  Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort: The Atherosclerosis Risk in Communities Study , 2006, Hypertension.

[50]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[51]  Kuan-Hung Lin,et al.  Uric acid and the development of hypertension. , 2010, Medical science monitor : international medical journal of experimental and clinical research.